The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

The Indian Pharmaceutical Alliance (IPA) has highlighted the importance of balancing innovation with affordability in the healthcare ecosystem while responding to the US Executive Order on Drug ...

Earlier this week, President Donald Trump signed an executive order that he claims will force Big Pharma to lower prescription drug prices paid by Americans to match the prices paid in other ...

The LNP Alliance brings together deep scientific expertise, proprietary lipid innovations, world-class formulation capabilities and analytical and drug efficacy services to support biopharma and ...

"Voyager"), announced today a co-discovery alliance with OmniAb, Inc. (NASDAQ: OABI, “OmniAb”) for the development of a novel bispecific antibody drug conjugate (“bsADC”) program targeting ...

The policy, known as most-favored-nation status, is intended to drive drug companies to lower prices domestically while other countries shoulder more of the cost. White House officials said Monday ...

EXCLUSIVE: Arts Alliance, the parent company of London’s Garden Studios, today launched a new co-production initiative aimed at supporting independent feature films. The programme will provide ...

They analysed how different activation states of the protein affect the cells. "It was shown that the diabetes drug pioglitazone influences the activity of PPARγ and thus inhibits the growth ...

VERAXA Biotech AG, a developer of innovative cancer therapies, has announced a partnership with OmniAb, Inc. to create a bispecific antibody drug conjugate (bsADC) program aimed at treating solid ...

A critical new drug could result from this discovery, they conclude. "This is a successful drug discovery program delivering second-generation rifamycins with improved efficacy specifically ...

A convergence of industry leaders, each bringing specialized expertise to drive innovation in LNP-based drug development The LNP Alliance brings together deep scientific expertise, proprietary ...